Manufacture of sterile medicinal products

EU GMP Annex 1: gap analysis, CCS and training

The revised Annex 1, in force since 25 August 2023, requires a contamination control strategy (CCS) and demonstrated control of the microbiological and particulate risks linked to premises, processes, equipment and products.

Areas covered

Aseptic filling Freeze-drying BFS-FFS Single-use Barrier technologies Utilities Media Fill Test Environmental monitoring Sterilisation Personnel training

Three services

1. Gap analysis

Review of all or part of your quality system – procedures, records, deviations, qualification and validation reports, environmental data – to identify significant gaps and propose an action plan: training, investments, procedures.

2. Contamination control strategy (CCS)

Review of existing documents and data, identification of those to be created, and a proposed overall CCS structure, ready to be presented during an inspection.

3. On-site training

Training of your teams on all or part of Annex 1, as a complement to the gap analysis.